Gossamer Bio (GOSS) Debt Ratio (2019 - 2026)
Gossamer Bio (GOSS) posted quarterly Debt Ratio of 0.04 for Q1 2024, down 60.98% year-over-year from 0.09 in Q2 2023, and down 7.2% quarter-over-quarter from 0.04 in Q4 2023.
Gossamer Bio (GOSS) Debt Ratio (2019 - 2026) Analysis & Trends
Gossamer Bio's Debt Ratio history runs 6 years deep, the most recent figure standing at 0.04 for Q1 2024.
- In Q1 2024, Debt Ratio fell 60.98% year-over-year to 0.04; the TTM figure through Mar 2024 stood at 0.04 (down 60.98% YoY), while the FY2023 annual figure was 0.04, down 54.01% from the prior year.
- Debt Ratio for Q1 2024 stood at 0.04, down from 0.04 in the prior quarter.
- The five-year high for Debt Ratio was 0.1 in Q2 2023, with the low at 0.04 in Q1 2024.
- The 5-year median for Debt Ratio is 0.07 (2021), against an average of 0.07.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio soared 65.68% in 2022, then slumped 60.98% in 2024.
- Gossamer Bio's Debt Ratio stood at 0.05 in 2020, then soared by 58.8% to 0.08 in 2021, then rose by 2.37% to 0.09 in 2022, then plunged by 54.01% to 0.04 in 2023, then dropped by 7.2% to 0.04 in 2024.
- Business Quant data shows GOSS's Debt Ratio at 0.04 in Q1 2024, 0.04 in Q4 2023, and 0.04 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Gossamer Bio | 49.15 Mn | -7.87 Mn | - | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.10 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.07 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.05 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.08 |
| Dec 31, 2019 | 0.07 |
| Sep 30, 2019 | 0.06 |